Others show that TROP-2 appears to have a strong role in differentiating non-neoplastic lesions such as Graves’ disease, hyperplastic nodules in FND, and hyperfunctioning adenoma from classic PTC but not the follicular variant of PTC.22 Here, TACSTD2 is linked to adenoma.